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Intercellular communication through gap junctions
(GJIC) is most likely relevant to maintaining the integrity
of the blood-retinal barrier. In this study, we investigated
the mechanism whereby high glucose enhances degrada-
tion of connexin 43 (Cx43), thus contributing to a decrease
in GJIC. The levels of Cx43 in bovine retinal endothelial
cells exposed to high glucose (25 mM) decreased about 50%
as compared with controls (5.5 mM glucose). Consistently,
the half-life of the protein decreased from 2.3 to 1.9 h. The
proteasome inhibitors MG132 and lactacystin prevented
the loss of Cx43 induced by high glucose and extended
Cx43 half-life. The amount of phosphorylated Cx43 in-
creased in high glucose and after proteasome inhibition.
Scrape-loading dye transfer experiments show that high
glucose is associated to a decrease of 40% in GJIC. Signif-
icantly, this reduction can be reversed by proteasome
inhibitors. The decrease in GJIC in cells exposed to high
glucose is associated with a loss of Cx43 from the plasma
membrane, as demonstrated by immunofluorescence and
biotinylation of cell-surface proteins. Results indicate
that increased phosphorylation of Cx43 under high glu-
cose is the mechanism targeting Cx43 for degradation by
a proteasome-dependent mechanism. Increased degrada-
tion of Cx43 and reduction of GJIC in high glucose may be
of physiological importance by contributing to endothe-
lial cell dysfunction associated with the breakdown of the
blood-retinal barrier in diabetic retinopathy.
Hyperglycemia and the consequent exposure of the intracel-
lular milieu of the retinal capillary endothelial cells to elevated
blood glucose concentrations have been implicated in the
pathogenesis of vascular complications in diabetes, including
the breakdown of the blood-retinal barrier (1, 2). The exact
biochemical and molecular mechanisms that transduce chronic
hyperglycemia into micro- and macrovascular complications of
the retina are not clear. However, it has been suggested that
several mechanisms play a role in the pathogenesis of diabetic
retinopathy; those include increased nonenzymatic glycation
(3), activation of aldose reductase (4), oxidative stress (3), in-
creased production of diacylglycerol, and stimulation of retinal
protein kinase C (PKC)1 (5). Despite the nature of such mech-
anisms, early cell dysfunction related to diabetic vascular com-
plications is often associated with abnormalities in cell-cell
communication and maintenance of cell homeostasis.
Gap junctions are intercellular-channels that permit the pas-
sage of small molecules such as small metabolites, ions, and
second messengers (6). These channels consist of two hemi-
channels, called connexons, that are located in the plasma
membrane of two adjacent cells. Each connexon is composed of
six subunits of the protein connexin. Gap junctions have an
important role in a variety of cellular processes including ho-
meostasis, morphogenesis, cell differentiation, and growth con-
trol (7).
Three connexin subtypes are expressed in the endothelium of
the blood vessels: Cx37, Cx40, and Cx43 (8). Endothelial cells
rely on a network of gap junctions for intercellular communi-
cation (9, 10). Previous studies have shown that intercellular
communication in endothelial cells is reduced under conditions
of hyperglycemia (11). Such a decrease in intercellular commu-
nication is most likely due to a reduction of the abundance of
connexin 43 (Cx43) in endothelial cells.
One of the most remarkable aspects of gap junction biosyn-
thesis is the exceptional metabolic lability of connexins. Al-
though the half-life of the great majority of plasma membrane
proteins exceeds 24 h, connexins present a rapid turnover rate,
with half-lives of only 1.5–5 h (12–14). Until the present time,
two proteolytic pathways have been implicated in connexin
turnover, the lysosome (14, 15) and the proteasome (13–17).
The mechanisms and upstream events that lead to the choice of
one degradation pathway over the other are largely unknown.
It has, however, been shown that both pathways coexist and
are active in a number of cell types and in a variety of experi-
mental and pathological conditions (18–20). For example, we
have previously shown that in response to specific stimuli,
proteasome is involved in the degradation of phosphorylated
Cx43 in lens epithelial cells (LEC) (17).
It has been widely shown that phosphorylation of Cx43 re-
sults in decreased intercellular communication through gap
junctions (GJIC), probably because of a reduction in abundance
at the plasma membrane (21–24). For example, it was shown
that in smooth muscle cells, high glucose induced the inhibition
of GJIC activity through hyperphosphorylation of Cx43 by PKC
(25). On the other hand, a recent study has shown that high
glucose inhibited GJIC activity by down-regulating Cx43 syn-
thesis in rat microvascular endothelial cells (11). We have
shown before that Cx43 is remarkably labile and that the
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ubiquitin proteasome pathway is involved in the degradation of
Cx43 in LEC (17). Further, we have suggested that the com-
bined action of phosphorylation and protein degradation by the
proteasome pathway acts as a mechanism of decreasing inter-
cellular communication in the LEC (17). By analogy, it is thus
conceivable that a similar mechanism may occur in retinal
endothelial cells.
To investigate the mechanism whereby hyperglycemia leads to
decreased intercellular communication in endothelial cells, we
have hypothesized that hyperglycemia may create the conditions
that favor increased degradation of Cx43, presumably involving
increased phosphorylation of the protein. A reduction in Cx43
half-life and a decreased abundance of Cx43 at the plasma mem-
brane would thus account for the reduced intercellular commu-
nication observed under conditions of hyperglycemia.
EXPERIMENTAL PROCEDURES
Cell Cultures—Bovine retinas were the source of capillaries used to
isolate cells for primary culture. Cow eyes were obtained from a local
slaughterhouse. Primary bovine retinal endothelial cells (BREC) cultures
were established from fresh calf eyes. Under sterile conditions, the retinas
were isolated and washed in Dulbecco’s modified Eagle’s medium
(DMEM), and pieces of adherent retinal pigment epithelial cells were
removed. The retinas were transferred to an enzyme solution containing
Pronase (100 g/ml), collagenase (500 g/ml), and DNase (70 g/ml) and
incubated with shaking at 37 °C for 20 min. After incubation, the retinal
digest was passed through 210- and 50-m nylon mesh, and the microves-
sels trapped on top of the 50-m mesh were collected in DMEM by
centrifugation. The fragments were resuspended in DMEM with 15%
fetal calf serum, 20 g/ml endothelial growth supplement (Roche Diag-
nostics, Mannheim, Germany), heparin (100 g/ml), and antibiotic-anti-
mycotic solution (Sigma), plated, and grown on fibronectin-coated dishes
in low glucose DMEM at 37 °C with 5% CO2. Cultures were passaged
every 7 to 10 days. For all experiments, cultures from passages three to
five were used. To determine the effect of high glucose on Cx43 expression
and GJIC activity, BREC were grown in low (5.5 mM) or high (25 mM)
D-glucose medium for 8 days to confluence.
Antibodies and Reagents—The rabbit polyclonal and mouse mono-
clonal anti-Cx43 antibodies were obtained from Zymed Laboratories
Inc. (San Francisco, CA). The mouse anti-Cx43 monoclonal antibody
was raised against a peptide sequence that represents amino acid
residues 360–376 of Cx43. Unless otherwise noted, all other reagents
were from Sigma, except MG132, which was obtained from Calbiochem
(Darmstadt, Germany). 12-O-tetradecanoylphorbol 13-acetate (TPA)
and MG132 were dissolved in Me2SO.
Gel Electrophoresis and Western Blotting—Cells exposed to normal
and high-glucose medium were washed, collected in phosphate-buffered
saline (PBS) solution by centrifugation, and cell pellets were frozen at
80 °C until use. The cells were resuspended in lysis buffer containing
10 mM Tris, pH 7.4, 1 mM EDTA, 1% Triton X-100, and 0.5% sodium
deoxycholate, supplemented with protease inhibitor mixture (Roche
Diagnostics), 2 mM phenylmethylsulfonyl fluoride, 10 mM iodoacet-
amide, 10 mM NaF, 500 M Na3VO4. The lysates were sonicated six
times for 3 s to completely disrupt all cells and then centrifuged at
16,000  g for 15 min. The supernatants were used to determine the
protein concentration by BCA reagent (Pierce) and then were denatured
with Laemmli buffer.
For studies involving total cell lysates, electrophoresis was per-
formed on 50-g aliquots of each sample on an SDS-12% polyacrylamide
gel and transferred to polyvinylidene fluoride (PVDF) membranes.
Membranes were probed with rabbit polyclonal or mouse monoclonal
antibodies against connexin 43. The signals were detected by ECL
system (Amersham Biosciences). Films were scanned and the optical
densities of the bands were measured with appropriate software. All
results are representative of at least three independent experiments.
Metabolic Labeling and Immunoprecipitation—For metabolic label-
ing with 35S, cells were rinsed with methionine-free medium prior to
incubation with [35S]methionine (Amersham Biosciences) 100 Ci/ml
for 1 h. The cells were then chased in DMEM supplemented with 0.5 mM
unlabelled methionine in the presence or absence of MG132 for 1, 2, or
4 h. The samples were resuspended in lysis buffer (190 mM NaCl, 50 mM
Tris-HCl, 6 mM EDTA, 2.5% Triton X-100, 0.2% SDS, pH 8.3) supple-
mented with protease inhibitor mixture (Roche Diagnostics), protein
phosphatase inhibitor set II (Calbiochem, La Jolla, CA), 2 mM phenyl-
methylsulfonyl fluoride, 10 mM iodoacetamide, 50 mM NaF, 500 M
Na3VO4. Cells were lysed by sonication, and supernatants were used for
immunoprecipitation using polyclonal antibodies directed against
Cx43. After centrifugation at 16,000  g, the supernatants were incu-
bated with antibodies directed against Cx43 for 3 h at 4 °C, followed by
incubation with protein A-Sepharose for 1 h. The samples were then
centrifuged, and the protein A-Sepharose sediments were resuspended
in Laemmli buffer and denatured at 37 °C for 30 min. Proteins were
resolved by SDS-PAGE, and the gels were dried and autoradiographed.
Semi-quantitative Reverse Transcription (RT)-PCR Analyses—RNA ex-
tracted from BREC grown in low and high glucose medium was simulta-
neously determined by semi-quantitative RT-PCR using the forward
primer 5-TTAAGGATCGTGTGAAGGGAAAGAG-3 and the reverse
primer 5-CTAGATCTCTAGGTCATCAGGCCG-3 for amplification of
Cx43, and the forward primer 5-AAGGAGAAGCTGTGCTACGTCGC-
CCTGG-3 and the reverse primer 5-GATCTTGATCTTCATTGTGCT-
GGGTGCC-3 for amplification of actin. For simultaneous amplification of
Cx43 and -actin, cDNAs were generated in the same RT reaction. To
confirm that amplification was in the linear region, separate tubes con-
taining increasing volumes of the RT reaction were used. Amplification
products were electrophoresed on a 1% agarose gel and stained with
ethidium bromide. Densitometry was performed at nonsaturating expo-
sures, and the Cx43/-actin ratios were determined.
Biotinylation of Cell-surface Proteins—The cell-surface proteins of
BREC were biotinylated. Dishes of confluent BREC cells (10-cm diam-
eter) were rinsed twice with 5 ml of ice-cold PBS containing 0.5 mM
MgCl2 and 1 mM CaCl2, followed by the addition of 3 ml of the same cold
solution containing 1 mg/ml freshly added Sulfo-NHS-SS-biotin
(Pierce). After 30 min at 4 °C, the medium was removed, and the plates
were washed three times with PBS containing 0.5 mM MgCl2, 1 mM
CaCl2, and 100 mM glycine. The cells were scraped in RIPA buffer (50
mM Tris-HCl, 150 mM NaCl, 5 mM EGTA containing 1% Triton, 0.5%
deoxycholate, 0.1% SDS and supplemented with protease inhibitor mix-
ture, 2 mM phenylmethylsulfonyl fluoride, 10 mM iodoacetamide, 10 mM
NaF, and 500 M Na3VO4; pH 7.5). After 10–20 min on ice the cells were
sonicated, and the homogenates were centrifuged at 16000  g for 10
min. The protein content of the supernatants was determined, and the
same quantity of protein was transferred to 1.5-ml Eppendorf microfuge
tubes containing 200 l of Neutravidin (Pierce). After 2 h of incubation
at 4 °C with agitation, the beads were washed four times with RIPA
buffer. The resulting pellets were resuspended in 150 l of 2 Laemmli
buffer and incubated for 1 h at 37 °C. The beads were pelleted, and the
proteins were resolved by SDS-PAGE, transferred to PVDF mem-
branes, and blotted against Cx43 antibodies.
Immunofluorescence—BREC grown on fibronectin-coated glass cov-
erslips were fixed with 4% paraformaldehyde in PBS. The samples were
then washed with PBS, permeabilized with 1% (v/v) Triton X-100 in
PBS, and blocked with goat serum (1:10) for 20 min prior to incubation
with primary mouse monoclonal antibody against connexin (1:25) for
1 h at room temperature. The specimens were rinsed in PBS and
mounted with Glycergel (Dako, Carpinteria, CA). All solutions were
made up in 0.02% (w/v) bovine serum albumin (Sigma) containing
0.02% sodium azide (Sigma) in PBS. For controls, primary antibodies
were omitted. For alkaline phosphatase treatment, the dephosphoryl-
ation reactions were carried out in lysis buffer after overnight incuba-
tion at 37 °C in the presence of alkaline phosphatase (5 units) from
Escherichia coli (Sigma).
Cell-cell Communication Assay—BREC grown on fibronectin-coated
glass coverslips were assessed for gap junction-mediated intercellular
coupling as described by Musil et al. (14). Briefly, the culture medium
from confluent cells was removed and saved. The cells were rinsed three
times with Hanks’ balanced salt solution containing 1% bovine serum
albumin, after which a 27-gauge needle was used to create multiple
scrapes through the cell monolayer in the presence of Dulbecco’s phos-
phate-buffered saline containing 0.5% rhodamine-dextran and 0.5%
Lucifer yellow. After 3 min of incubation at room temperature, the
culture was rinsed three times with Hanks’ balanced salt solution
containing 1% bovine serum albumin and then incubated for an addi-
tional 8 min in the saved culture medium to allow the loaded dye to
transfer to adjoining cells. The cells were then rinsed and fixed with 4%
paraformaldehyde and viewed using a fluorescence microscope with a
UV light source.
Statistical Analysis—Data are expressed as means  S.D. or S.E.
Comparison between groups was performed with a Student’s t test.
RESULTS
High Glucose Leads to a Decrease in the Amount of Cx43 by
a Proteasome-dependent Mechanism—It has previously been
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shown that hyperglycemia leads to a decrease in total Cx43 in
various cell types (11, 25, 26). To investigate the mechanisms
whereby high glucose leads to decreased Cx43 in BREC, the
amount of total Cx43 was determined by Western blotting (Fig.
1A). The levels of Cx43 decreased about 50% in cells exposed to
25 mM glucose for 8 days, as compared with controls (cells
incubated in 5.5 mM glucose; see Fig. 1B). Because the protea-
some was reported to be involved in Cx43 degradation (13–17),
we further evaluated the participation of the proteasome on
Cx43 degradation in high glucose by treating BREC with the
proteasome inhibitors MG132 (Fig. 1, A and B) or lactacystin
(data not shown). Data shown in Fig. 1 clearly indicate that
proteasome inhibitors prevent, to a significant extent, the loss
of Cx43 induced by high glucose. In fact, the levels of Cx43 in
cells exposed to high glucose were restored to about 85% of the
initial levels by proteasome inhibitors (Fig. 1B).
Cx43 Is Stabilized by Proteasome Inhibitors under High Glu-
cose—Because RT-PCR experiments suggest that the levels of
mRNA for Cx43 are not remarkably altered after exposure of
BREC to high glucose (data not shown), the decreased amounts
of Cx43 observed under high glucose are likely to be related to
an increased turnover of the protein. To determine the half-life
of Cx43, cells were metabolically labeled with [35S]methionine
for 1 h and then chased for 1, 2, or 4 h. The data presented in
Fig. 2 shows that the half-life of Cx43 in cells exposed to high
glucose decreased from 2.3 h, in control cells, to 1.9 h. To
further determine whether the increased turnover of Cx43 in
high glucose was associated with increased degradation of the
protein by a proteasome-dependent mechanism, proteins in
cells were metabolically labeled with [35S]methionine for 1 h
and chased with unlabelled medium in the presence of the
proteasome inhibitor MG132. Data shows that Cx43 degrada-
tion under high glucose is, at least in part, prevented by the
proteasome inhibitor MG132 (Fig. 2) and by the more specific
inhibitor lactacystin (data not shown). The half-life of Cx43 in
cells grown in high glucose increased from 1.9 h to 3.4 h when
the proteasome was inhibited. The fact that proteasome inhib-
itors extended Cx43 half-life beyond the half-life of the protein
in controls indicates that proteasome has a role in constitutive
degradation of Cx43 and that high glucose may create the
conditions that favor increased degradation of the protein by a
proteasome-dependent mechanism.
Increased Degradation of Cx43 under High Glucose Is As-
sociated with Increased Phosphorylation of the Protein—High
glucose was shown to induce PKC-mediated phosphorylation
of Cx43, which in turn may stimulate protein degradation
(11, 25, 26).
The effect of high glucose on phosphorylation of Cx43 in-
duced by PKC was confirmed by incubating cells with stauro-
sporine, an inhibitor of PKC. The decrease in the levels of Cx43
in cells exposed to high glucose was prevented, at least in part,
by incubating cells with staurosporine (Fig. 3, A and B). Con-
sistently, incubation with TPA, an activator of PKC, resulted in
a decrease of about 85% in the content of Cx43 (Fig. 3B). These
results show that high glucose may activate PKC, which, in
turn, may hyperphosphorylate Cx43, leading to its increased
degradation. Results obtained in our laboratory showed that
the phosphorylated forms of Cx43 are preferentially degraded
by a mechanism that involves the proteasome (17). To investi-
gate whether proteasome is the mechanism leading to in-
creased degradation of phosphorylated Cx43 under high glu-
cose, Cx43 was immunoprecipitated from lysates of cells
incubated under high glucose in the presence of proteasome
inhibitors. Proteins were separated by SDS-PAGE and trans-
ferred to PVDF membranes that were probed with antibodies
directed against the phosphoserine/phosphothreonine residues
(Fig. 4A) or polyclonal antibodies directed against Cx43 (Fig.
4B). The ratio of phosphorylated/nonphosphorylated (P/NP)
Cx43 was calculated and plotted in a graph (Fig. 4D). The
results show that the ratio P/NP Cx43 increased 2-fold in cells
incubated under high glucose and, more importantly, inhibi-
tion of the proteasome led to a 3-fold increase in the ratio of
P/NP Cx43, as compared with control cells incubated under low
glucose. On the other hand, the ratio of P/NP Cx43 was not
significantly altered when the PKC inhibitor staurosporine was
added to cells exposed to high glucose. These results suggest
that phosphorylation of Cx43 in cells exposed to high glucose
mayactasasignal fordegradationoftheproteinbyaproteasome-
dependent mechanism.
High Glucose Leads to Decreased Intercellular Communica-
tion by a Proteasome-dependent Mechanism—The functional
FIG. 1. Effect of high glucose and proteasome inhibition on the
amount of Cx43. A, BREC were incubated in medium containing 5.5
mM (low glucose) or 25 mM glucose (high glucose) for 8 days. During the
last 4 h of incubation, cells were exposed to 40 M MG132. After the
treatments, the proteins were separated by SDS-PAGE, transferred to
PVDF membranes, and probed with monoclonal antibodies directed
against Cx43; calnexin on the same samples is included to demonstrate
comparable loading of the lanes. B, the intensity of the bands was
determined by laser scanning the films followed by quantitative densi-
tometric analysis; results are plotted in a graph. Data are means S.E.
(n  3 per group). *, p  0.05, difference from control incubated in low
glucose as determined by unpaired two-tailed Student’s t test.
FIG. 2. Effect of proteasome inhibitors in half-life of Cx43 un-
der high glucose. BREC were labeled with [35S]methionine for 1 h
either in the presence or absence of 40 M MG132. The cells were then
chased for 1, 2, or 4 h with non-labeled medium, and Cx43 was immu-
noprecipitated using a polyclonal antibody. Immunoprecipitated pro-
teins were separated by SDS-PAGE and autoradiographed. E, BREC
grown in low glucose in the absence of MG132; , BREC grown in low
glucose in the presence of MG132; , BREC grown in high glucose in
the absence of MG132; f, BREC grown in high glucose in the presence
of MG132. Quantification of the bands was performed using a Phospho-
rImager analyser (Storm 860, Amersham Biosciences). The data pre-
sented are representative of two independent experiments.
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implications of increased Cx43 degradation in high glucose was
evaluated by scrape-loading dye transfer experiments. The in-
tercellular communication was quantified as the distance trav-
eled by the Lucifer yellow dye after scrape-loading (Fig. 5A).
The GJIC decreased about 40% in cells exposed to high glucose
(Fig. 5B). Conversely, but not surprisingly, proteasome inhibi-
tors had the opposite effect in GJIC, leading to an increase of
about 20% in the distance traveled by the dye (Fig. 5B). How-
ever, under high glucose, proteasome inhibitors not only re-
stored the GJIC to control levels, but also increased intercellu-
lar communication 2-fold, as compared with controls incubated
under low glucose. Taken together, these results suggest that
high glucose has a direct impact in GJIC by a mechanism that
involves increased degradation of Cx43 in a proteasome-de-
pendent manner.
Treatment of BREC, grown in high glucose with the PKC
inhibitor staurosporine, resulted in an increase of GJIC of about
36%. On the other hand, and as predicted, treatment with TPA
resulted in a dramatic inhibition (about 80%) of GJIC.
Inhibition of GJIC Is the Direct Result of Decreased Abun-
dance of Cx43 at the Plasma Membrane—Intercellular commu-
nication is usually associated with the abundance of functional
gap junction plaques, at cell-cell interfaces. Thus, an alteration
of intercellular communication is either associated with
changes in gap junction activity or with the levels of Cx43 at
the plasma membrane available to form gap junctions. To in-
vestigate whether the decrease of GJIC in high glucose is
related to alterations in the subcellular distribution of Cx43,
BREC were immunostained with antibodies directed against
Cx43 and imaged by confocal microscopy. In control cells, Cx43
was localized both to the plasma membrane, to cell-cell con-
tacts, and intracellularly. In cells exposed to high glucose, there
is a clear decrease in the abundance of Cx43 detected at the
plasma membrane (Fig. 6A). The amount of Cx43 at the plasma
membrane was determined as the fluorescent punctate at the
site of contact between adjacent cells (Fig. 6B). The involve-
FIG. 4. Effect of the proteasome inhibitors on phosphorylation
of Cx43. Cx43 was immunoprecipitated from cell lysates of BREC
incubated with MG132 or staurosporine using polyclonal antibodies.
Immunoprecipitated proteins were separated by SDS-PAGE, trans-
ferred to PVDF membranes, and probed with antibodies directed
against phosphorylated residues of serine/threonine (A) or polyclonal
antibodies to Cx43 (B). C, enzymatic dephosphorylation of Cx43. Cell
lysates were incubated in the absence or presence of alkaline phospha-
tase (AP) from E. coli at 37 °C overnight. The intensity of the bands was
determined by laser scanning the films followed by quantitative densi-
tometric analysis. D, the ratio of P/NP Cx43 was calculated and plotted
in a graph. Data are means  S.E. (n  3 per group). *, p  0.05,
difference from control incubated in low glucose as determined by
unpaired two-tailed Student’s t test.
FIG. 3. Effect of phosphorylation on the amount of Cx43. A,
BREC were incubated with a medium containing 5.5 or 25 mM glucose
for 8 days. During the last 1 h or 40 min of incubation, cells were
exposed to 100 nM staurosporine or 80 nM TPA, respectively. After the
treatments, the proteins were separated by SDS-PAGE, transferred to
PVDF membranes, and probed with monoclonal antibodies directed
against Cx43; the amount of calnexin on the same sample is included to
demonstrate comparable loading of the lanes. B, the intensity of the
bands was determined by laser scanning of the films followed by quan-
titative densitometric analysis; results are plotted in a graph. Data are
means  S.E. (n  3 per group). *, p  0.05, difference from control
incubated in low glucose as determined by unpaired two-tailed Stu-
dent’s t test.
FIG. 5. Effect of high glucose and proteasome inhibition on
GJIC activity. A, BREC exposed to 5.5 or 25 mM glucose for 8 days
were incubated with 40 M MG132, 100 nM staurosporine, or 80 nM
TPA. The cells were then assayed for intercellular communication by
Lucifer yellow dye transfer after scrape-loading. B, the intercellular
communication was evaluated as the average distance traveled by the
Lucifer yellow dye along the monolayer and is represented as a histo-
gram. Data are means  S.D. (n  3 per group). *, p  0.05, difference
from control incubated in low glucose as determined by unpaired two-
tailed Student’s t test.
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ment of the proteasome on Cx43 redistribution in high glucose
was determined by incubating cells with the proteasome inhib-
itor MG132. Results presented in Fig. 6A show that proteasome
inhibition reversed the redistribution induced by high glucose,
with the amount of Cx43, at the plasma membrane, being
similar to that observed in control cells. These results indicate
that inhibition of GJIC in high glucose is directly related to the
amount of Cx43 available to form gap junctions at the plasma
membrane. Moreover, the extraction of Cx43 from plasma
membrane occurs through a proteasome-dependent mecha-
nism and results in an increased degradation of Cx43 in retinal
capillary endothelial cells.
The amount of Cx43 at the plasma membrane was further
assessed by biotinylation of cell-surface proteins. The amount
of biotinylated Cx43 decreased in cells exposed to high glucose,
as compared with control cells (Fig. 6C). However, treatment
with MG132 resulted in a significant increase in the amount of
biotinylated Cx43 recovered in lysates of BREC exposed to high
glucose (Fig. 6C).
Taken together, these results support a model in which hy-
perglycemia creates the conditions that favor targeting of mem-
brane Cx43 to degradation by a proteasome-dependent mech-
anism. The results presented in this study, together with
previous reports, suggest that phosphorylation of Cx43 is the
stimulus targeting Cx43 for degradation by a proteasome-de-
pendent mechanism. Moreover, increased degradation of Cx43
results in a decrease in the amount of Cx43 available to form
gap junctions at the plasma membrane, leading to a reduction
in intercellular communication in endothelial cells.
DISCUSSION
Previous studies demonstrated that high glucose induces a
reduction of GJIC (25–28). More recently, Sato et al. (11)
showed that the decreased levels of Cx43 were partially asso-
ciated with a down-regulation of Cx43 in response to hypergly-
cemia. Endothelial cells exposed to high glucose showed a de-
crease of about 30% in Cx43 mRNA, whereas the total amount
of the protein decreased 45%, what suggests that Cx43 degra-
dation might also be enhanced in hyperglycemia (11). Data
reported in this study show that the amount of Cx43 in BREC
decreased about 50% in high glucose, whereas the levels of
Cx43 mRNA do not vary significantly. We have shown previ-
ously (17) in other cell types that in addition to the lysosome,
Cx43 abundance can be regulated by a ubiquitin-proteasome-
dependent mechanism. Thus, we hypothesized that the reduc-
tion of Cx43 induced by high glucose might be associated to an
increase in the turnover of the protein. In support of this
hypothesis is the observation that the half-life of Cx43 in BREC
exposed to high glucose decreased about 20% (this study). Most
likely, the lysosome is the major site for constitutive degrada-
tion of Cx43. However, it has been well established that pro-
teasome is also involved in degradation of Cx43 in a number of
cell types (13–17). Data obtained in this study show, for the
first time, that the proteasome is involved in degradation of
Cx43 in blood retinal endothelial cells in high glucose. Signif-
icantly, we have further shown that degradation of Cx43 by a
proteasome-dependent mechanism can be enhanced by protein
phosphorylation and results in decreased GJIC (17). The evi-
dence for proteasomal degradation of Cx43 is such that it has
been considered a novel mechanism for regulating intercellular
communication (14, 17). It has been shown that phosphoryla-
tion of Cx43 by various kinases, including PKC (23, 34), mito-
gen-activated protein kinase (24, 29), and the v-Src tyrosine
protein kinase (29, 30), all result in decreased intercellular
communication. We have suggested before (17) that phospho-
rylation of Cx43 is the signal that targets Cx43 for degradation
by a proteasome-dependent mechanism.
The pathways that transduce hyperglycemia into increased
degradation of Cx43 are largely unknown, as are the triggering
signals and the mechanism for extraction of Cx43 from plasma
membrane. However, by analogy to what has been observed in
other cell systems and based upon accepted models for regula-
tion of GJIC, it is reasonable to suggest that phosphorylation of
Cx43 is the upstream signaling event that triggers the degra-
dation of the protein by a proteasome-dependent mechanism.
Indeed, we show in the present report that activation of PKC is
required to phosphorylate Cx43 in cells exposed to high glu-
cose, as revealed by the inhibitory effect of staurosporine.
There is ample evidence in the literature to suggest that hy-
FIG. 6. Effect of high glucose and proteasome inhibition on
distribution of Cx43 at the plasma membrane. A, BREC exposed to
5.5 or 25 mM glucose for 8 days were incubated with 40 M MG132, 100
nM staurosporine, or 80 nM TPA. The cells were then fixed and stained
with antibodies directed against Cx43 and imaged by confocal micros-
copy. B, the amount of Cx43 at the plasma membrane was determined
as the fluorescent punctate at the site of contact between adjacent cells;
results are plotted in a graph. BREC were incubated with a medium
containing 5.5 or 25 mM glucose for 8 days. During the last 4 h of
incubation, cells were exposed to 40 M MG132. The cells were then
surface-labeled with biotin, and the biotinylated proteins were isolated
with Neutravidin beads. C, the isolated proteins were separated by
SDS-PAGE, transferred to PVDF membranes, and probed with mono-
clonal antibodies to Cx43. Data are means  S.D. (n  3 per group). *,
p 0.05, difference from control incubated in low glucose as determined
by unpaired two-tailed Student’s t test.
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perglycemia and diabetes are associated with increased ac-
tivity of PKC (25, 26, 31–33). Moreover, hyperphosphoryla-
tion of Cx43 in conditions of hyperglycemia has been widely
demonstrated (25, 26, 32). Multiple isoforms of PKC, includ-
ing PKC , 1, 2, and , were shown to be activated in
response to high glucose (34–36). More importantly, activa-
tion of various isoforms of PKC is implicated in vascular
dysfunction associated with diabetes (35–37). At least part of
these isoforms were shown to phosphorylate Cx43 (38–40),
presumably targeting the protein for degradation (17). At
present, the specific isoforms that lead to increased phospho-
rylation of Cx43 in high glucose, and presumably in diabetes,
remain to be elucidated. However, data presented in this
report clearly show an association between exposure of reti-
nal endothelial cells to high glucose, hyperphosphorylation of
Cx43,andincreaseddegradationoftheproteinbyaproteasome-
dependent mechanism.
Consistent with the above model, we also demonstrate that
inhibition of the proteasome leads to an accumulation of phos-
phorylated Cx43. These data, together with the observation that
staurosporine (an inhibitor of PKC) and TPA (an activator of
PKC) have opposite effects upon the half-life of the protein,
strongly suggest that phosphorylation of Cx43 leads to its extrac-
tion from the plasma membrane and increased degradation.
The physiological implications of hyperglycemia in GJIC
have been extensively demonstrated in various cell types and
systems. For example, in retinal pigment epithelium (41), epi-
didymal endothelial cells (11, 27), and smooth muscle cells (25),
it has been shown that high glucose reduced the intercellular
communication. Significantly, the decrease in intercellular
communication induced by high glucose, in most studies, can be
reversed by PKC inhibitors (25, 28, 32), thus indicating that
phosphorylation is the mechanism whereby hyperglycemia re-
duces intercellular communication.
Data presented in this study consistently show that high
glucose reduces GJIC and also that such reduction involves
the activation of PKC and, most likely, other kinases (be-
cause the intercellular communication is not completely re-
versed by PKC inhibitor). More importantly, we propose an
integrated model in which increased phosphorylation of Cx43
(mostly by PKC) under high glucose leads to extraction of
Cx43 from the plasma membrane and increased degradation
of Cx43, with the consequent reduction of GJIC. To demon-
strate that reduction of GJIC is the direct result of the
decreased abundance of Cx43 available to form gap junction
plaques and not the result of alterations on the activity of gap
junctions, we performed biotinylation of membrane proteins
and imaged cell cultures by confocal microscopy. Data ob-
tained confirm that high glucose leads to a reduction on the
abundance of Cx43 forming gap junctions at the plasma
membrane and that such reduction can be prevented by in-
hibitors of the proteasome.
Taken together, the data presented in this report support a
model in which hyperphosphorylation of Cx43 in hyperglycemia
constitutes the triggering signal for Cx43 degradation by a pro-
teasome-dependent mechanism. We suggest that impairment of
gap junction intercellular communication activity between vas-
cular endothelial cells is involved in the breakdown of the blood-
retinal barrier in chronic hyperglycemia (11). Increased degrada-
tion of Cx43 and reduction of GJIC may thus contribute to the
endothelial cell dysfunction associated with breakdown of the
blood-retinal barrier associated with diabetic retinopathy.
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